Costs and quality of life in diabetic macular edema: Canadian burden of diabetic macular edema observational study (C-REALITY)

Journal of Ophthalmology

Volumn 2014, Issue , 2014, Pages

  Gonder, John R ^a   Walker, Valery M ^b   Barbeau, Martin ^c   Zaour, Nancy ^c   Zachau, Bryan H ^b   Hartje, James R ^b   Li, Ruihong ^c  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b OPTUM   (United States)

^c Novartis Pharmaceuticals Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899532134     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2014/939315     Document Type: Article

References (28)

1. Moss S. E., Klein R., Klein B. E., Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994 101 6 1061 1070 2-s2.0-0028275559 (Pubitemid 24183163)
2. Ciulla T. A., Amador A. G., Zinman B., Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003 26 9 2653 2664 2-s2.0-0041358796 10.2337/diacare.26.9.2653 (Pubitemid 37055447)
3. Johnson M. W., Etiology and treatment of macular edema. American Journal of Ophthalmology 2009 147 1 11.e1 21.e1 2-s2.0-57549102804 10.1016/j.ajo.2008. 07.024
4. Petrella R. J., Blouin J., Davies B., Barbeau M., Prevalence, demographics, and treatment characteristics of visual impairment due to diabetic macular edema in a representative Canadian cohort. Journal of Ophthalmology 2012 2012 6 159167 10.1155/2012/159167
5. The cost of vision loss in Canada: summary report, 2009, http://www.cnib.ca/eng/cnib%20document%20library/research/summaryreport-covl.pdf
6. Mazhar K., Varma R., Choudhury F., McKean-Cowdin R., Shtir C. J., Azen S. P., Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology 2011 118 4 649 655 2-s2.0-79953323636 10.1016/j.ophtha.2010.08.003
7. Canadian Diabetes Association, An economic tsunami: the cost of diabetes in Canada. 2009, http://www.diabetes.ca/documents/get-involved/FINAL-Economic- Report.pdf
8. American Academy of Ophthamology Retina Panel, Preferred Practice Pattern Guidelines. Diabetic Retinopathy 2008 San Franciso, Calif, USA American Academy of Ophthamology
9. O'Brien J. A., Patrick A. R., Caro J., Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Services Research 2003 3, article 1 2-s2.0-3042585010 10.1186/1472-6963-3-1
10. Shea A. M., Curtis L. H., Hammill B. G., Kowalski J. W., Ravelo A., Lee P. P., Sloan F. A., Schulman K. A., Resource use and costs associated with diabetic macular edema in elderly persons. Archives of Ophthalmology 2008 126 12 1748 1754 2-s2.0-58149240462 10.1001/archopht.126.12.1748
11. Statistics Canada,. Consumer price index, http://www.statcan.gc.ca/ tables-tableaux/sum-som/l01/cst01/econ161a-eng.htm
12. Ontario Ministry of Health and Long-Term Care, Ontario health insurance (OHIP) schedule of benefits and fees. Physician services. http://www.health.gov. on.ca/english/providers/program/ohip/sob/sob-mn.html
13. Ontario Case Costing Initiative (OCCI), OCCI Costing analysis tool. Fiscal year. 2009, http://www.occp.com/mainPage.htm
14. Cruess A., Zlateva G., Xu X., Rochon S., Burden of illness of neovascular age-related macular degeneration in Canada. Canadian Journal of Ophthalmology 2007 42 6 836 843 2-s2.0-38149099226 10.3129/I07-153
15. Statistics Canada, Average hourly wages. 2011, http://www.statcan.gc.ca/ tables-tableaux/sum-som/l01/cst01/labr69a-eng.htm
16. Ontario Ministry of Long-Term Care, Drugs funded by Ontario drug benefit program. http://www.health.gov.on.ca/english/providers/program/drugs/odbf- eformulary.html
17. Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., Hays R. D., Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology 2001 119 7 1050 1058 2-s2.0-0034945828 (Pubitemid 32652197)
18. Cheung K., Oemat M., Oppe M M., User guide: basic information on how to use EQ-5D. 2009, http://www.euroqol.org/fileadmin/user-upload/Documenten/PDF/ User-Guide-v2-March-2009.pdf
19. Hariprasad S. M., Mieler W. F., Grassi M., Green J. L., Jager R. D., Miller L., Vision-related quality of life in patients with diabetic macular oedema. British Journal of Ophthalmology 2008 92 1 89 92 2-s2.0-38349171212 10.1136/bjo.2007.122416
20. Browning D. J., McOwen M. D., Bowen R. M. Jr., O'Marah T. L., Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004 111 4 712 715 2-s2.0-1842476679 10.1016/j.ophtha.2003.06.028 (Pubitemid 38429668)
21. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Archives of Ophthalmology 1985 103 12 1796 1806 10.1001/archopht.1985.01050120030015
22. Mitchell P., Bandello F., Schmidt-Erfurth U., Lang G. E., Massin P., Schlingemann R. O., Sutter F., Simader C., Burian G., Gerstner O., Weichselberger A., The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011 118 4 615 625 2-s2.0-79953311138 10.1016/j.ophtha.2011.01.031
23. Lee L. J., Yu A. P., Cahill K. E., Oglesby A. K., Tang J., Qiu Y., Birnbaum H. G., Direct and indirect costs among employees with diabetic retinopathy in the United States. Current Medical Research and Opinion 2008 24 5 1549 1559 2-s2.0-44349135017 10.1185/030079908X297303 (Pubitemid 351741588)
24. Suñer I. J., Kokame G. T., Yu E., Ward J., Dolan C., Bressler N. M., Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Investigative Ophthalmology & Visual Science 2009 50 8 3629 3635 2-s2.0-68349113753 10.1167/iovs.08-3225
25. Soubrane G., Cruess A., Lotery A., Pauleikhoff D., Monès J., Xu X., Zlateva G., Buggage R., Conlon J., Goss T. F., Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Archives of Ophthalmology 2007 125 9 1249 1254 2-s2.0-34548604340 10.1001/archopht.125.9.1249 (Pubitemid 47403034)
26. Lloyd A., Nafees B., Gavriel S., Rousculp M. D., Boye K. S., Ahmad A., Health utility values associated with diabetic retinopathy. Diabetic Medicine 2008 25 5 618 624 2-s2.0-42549093519 10.1111/j.1464-5491.2008.02430.x (Pubitemid 351590891)
27. Fenwick E. K., Xie J., Ratcliffe J., Pesudovs K., Finger R. P., Wong T. Y., Lamoureux E. L., The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Investigative Ophthalmology & Visual Science 2012 53 2 677 684 2-s2.0-84859246987
28. Sharma S., Hollands H., Brown G. C., Brown M. M., Shah G. K., Sharma S. M., The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathy. Current Opinion in Ophthalmology 2001 12 3 230 234 2-s2.0-0034994663 10.1097/00055735-200106000-00016 (Pubitemid 32525958)